Related Experiment Video
Updated: Jun 5, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Clot waveform analysis in hemophilia carriers
Eya Drissi1, Fatma Ben Lakhal, Ons Ghali
1Biological Hematology Department, Aziza Othmana Hospital, Tunis, Tunisia.
In recent years, there has been a growing interest in the activated partial thromboplastin time clot waveform analysis (APTT-CWA), which reflects clot formation. It was mainly studied in hemophilia and disseminated intravascular coagulation. The aim of this study was to evaluate the usefulness of APTT-CWA in hemophilia carriers. This was a cross-sectional study including hemophilia carriers and healthy women volunteers. Bleeding assessment was performed using the ISTH-BAT. Laboratory assessment included APTT, APTT-CWA and FVIII:C or FIX:C. Thirty-two hemophilia carriers and 30 women as a control group were recruited. APTT was prolonged in 14 carriers and none of controls. Tmax 1 and Tmax 2 were significantly prolonged in hemophilia carriers compared to controls. Max 1 and Max 2 were significantly lower in carriers. Using ROC analysis, APTT-CWA parametrs cut-offs showed good sensitivity and specificity in discriminating between carriers and controls. When comparing bleeders and nonbleeders carriers, a significant difference was noted in Max 2, Min 2, Tmax 1 and Tmax 2. No correlation was found between APTT and bleeding score, nor between FVIII:C and Max 1. A positive significant correlation of FVIII:C with Max 2 was found. A negative and significant correlation of FVIII:C with Tmax 1, Tmax 2 and Min 2 was noticed. The APTT-CWA seems to be a good tool to evaluate bleeding tendency or detecting coagulation factor deficiency. Additional research efforts are warranted to explore the potential of APTT-CWA for identifying hemophilia carriers.
In recent years, there has been a growing interest in the activated partial thromboplastin time clot waveform analysis (APTT-CWA), which reflects clot formation. It was mainly studied in hemophilia and disseminated intravascular coagulation. The aim of this study was to evaluate the usefulness of APTT-CWA in hemophilia carriers. This was a cross-sectional study including hemophilia carriers and healthy women volunteers. Bleeding assessment was performed using the ISTH-BAT. Laboratory assessment included APTT, APTT-CWA and FVIII:C or FIX:C. Thirty-two hemophilia carriers and 30 women as a control group were recruited. APTT was prolonged in 14 carriers and none of controls. Tmax 1 and Tmax 2 were significantly prolonged in hemophilia carriers compared to controls. Max 1 and Max 2 were significantly lower in carriers. Using ROC analysis, APTT-CWA parametrs cut-offs showed good sensitivity and specificity in discriminating between carriers and controls. When comparing bleeders and nonbleeders carriers, a significant difference was noted in Max 2, Min 2, Tmax 1 and Tmax 2. No correlation was found between APTT and bleeding score, nor between FVIII:C and Max 1. A positive significant correlation of FVIII:C with Max 2 was found. A negative and significant correlation of FVIII:C with Tmax 1, Tmax 2 and Min 2 was noticed. The APTT-CWA seems to be a good tool to evaluate bleeding tendency or detecting coagulation factor deficiency. Additional research efforts are warranted to explore the potential of APTT-CWA for identifying hemophilia carriers.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
06:16Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
Published on: April 19, 2024
Related Concept Videos
Clot Retraction and Fibrinolysis
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...